Express Scripts ClearNetworkSM offers employers and health plans a new option for simple, "cost-plus" pharmacy pricing for brand, generic, and specialty medications. "We are constantly innovating to ...

You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...

One week from now, national pharmacy benefit manager Express Scripts is expected to terminate its coverage with locally-owned Martella's Pharmacy. Our Emily Marines took a deeper dive into PBMs to ...

(Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover ...

They're the two biggest pharmacy benefits managers in the world, and they compete against each other every day. While CVS Health boasts a higher market cap thanks to its retail pharmacies, Express ...

Pharmacy benefit manager Express Scripts, which had been taken to a Massachusetts court for allegedly overcharging for some injured workers' prescriptions, has now settled the case for $3.2 million, ...

Shortly after a new survey revealed that health plans’ satisfaction with pharmacy benefit managers (PBMs) is down, Centene announced this week that it is switching to Express Scripts from CVS Caremark ...

NEW YORK (Reuters) - Express Scripts Inc will buy health insurer WellPoint Inc's NextRx prescription business for $4.68 billion, becoming the No. 2 U.S. pharmacy benefit manager while gaining more ...

The company that manages Tricare's pharmacy benefits will give thousands of independent and community pharmacies that left the network last month an opportunity to rejoin -- but it's unclear whether ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and ...